CS logo
small CS logo
Medical Corporation Heishinkai OPHAC Hospital

Osaka Shi, Osaka, Japan
Private hospital in Osaka
〒532-0003 Osaka, Yodogawa Ward, Miyahara, 4 Chome−1−29 大阪治験病院(平心会)

About Medical Corporation Heishinkai OPHAC Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Medical Corporation Heishinkai OPHAC Hospital


During the past decade, Medical Corporation Heishinkai OPHAC Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medical Corporation Heishinkai OPHAC Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Kowa Company, Ltd." with 3 trials sponsored, "AnGes, Inc." with 2 trials sponsored and "Abivax S.A." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Corporation Heishinkai OPHAC Hospital" #1 collaborator was "Japan Agency for Medical Research and Development" with 2 trials as a collaborator, "EPS Corporation" with 1 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Medical Corporation Heishinkai OPHAC Hospital


According to Clinical.Site data, the most researched conditions in "Medical Corporation Heishinkai OPHAC Hospital" are "Dyslipidemias" (3 trials), "Healthy" (3 trials), "Atopic Dermatitis" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Medical Corporation Heishinkai OPHAC Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Medical Corporation Heishinkai OPHAC Hospital


Most popular intervention types in "Medical Corporation Heishinkai OPHAC Hospital" are "Drug" (16 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Crisaborole ointment 2%" (2 trials), "Vehicle" (2 trials), "13vPnC" (1 trials) and "20vPnC" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Medical Corporation Heishinkai OPHAC Hospital


The vast majority of trials in "Medical Corporation Heishinkai OPHAC Hospital" are 17 trials for "All" genders and 4 trials for "Male" genders.

Clinical Trials Status at Medical Corporation Heishinkai OPHAC Hospital


Currently, there are NaN active trials in "Medical Corporation Heishinkai OPHAC Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Medical Corporation Heishinkai OPHAC Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medical Corporation Heishinkai OPHAC Hospital, 9 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".